ZILRETTA

Peak

triamcinolone acetonide extended-release injectable suspension

NDAINTRA-ARTICULARFOR SUSPENSION, EXTENDED RELEASE
Approved
Oct 2017
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Aug 4, 2031
65 months away
Patent Expiry
Aug 4, 2031

Patent Records (2)

Patent #ExpiryTypeUse Code
8828440
Aug 4, 2031
Product
—
9555048
Aug 4, 2031
U-2151
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers